Back
Zevra Therapeutics Stock Predictions
Notable investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
41
ZVRA
Zevra Therapeutics
Last Price:
$9.02
Seasonality Move:
26.33%
7 Day Trial
ALL ACCESS PASS
$
7
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compaZevra Therapeutics Stock Forecast
-
Over the next 52 weeks, Zevra Therapeutics has on average historically risen by 19.6% based on the past 10 years of stock performance.
-
Zevra Therapeutics has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Zevra Therapeutics Stock Undervalued?The current Zevra Therapeutics [ZVRA] share price is $9.04. The Score for ZVRA is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
ZVRA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Zevra Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Zevra Therapeutics has on average historically risen by 19.6% based on the past 10 years of stock performance.
Zevra Therapeutics Stock Rating
Sell
41
Zevra Therapeutics (ZVRA)
is a Sell
Is Zevra Therapeutics overpriced?
-
Zevra Therapeutics has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Zevra Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
zevra.com
52-Week Data
52-Week High:
9.76
52-Week Low:
4.20
Prediction Charts
Market Cap:
494.3M
Price in USD:
9.04
Volume:
560K
Beta:
1.81
Technical Analysis
SMA50:
8.11
SMA100:
7.94
SMA200:
8.11
52-Wk Change:
107.34%
Stock Predictions
-
Is Zevra Therapeutics stock public?Yes, Zevra Therapeutics is a publicly traded company.
-
What is the Zevra Therapeutics stock quote today?The Zevra Therapeutics stock price is 9.04 USD today.
-
How to buy Zevra Therapeutics stock online?You can buy Zevra Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jun-2 | 8.61 | 8.66 | 8.81 | 8.54 |
| Jun-3 | 8.68 | 8.87 | 8.94 | 8.56 |
| Jun-4 | 8.81 | 8.95 | 9.06 | 8.78 |
| Jun-5 | 8.97 | 8.83 | 9.11 | 8.78 |
| Jun-6 | 8.97 | 9.26 | 9.38 | 8.93 |
| Jun-9 | 9.40 | 9.19 | 9.41 | 9.02 |
| Jun-10 | 9.25 | 9.28 | 9.42 | 9.05 |
| Jun-11 | 9.35 | 9.38 | 9.62 | 9.28 |
| Jun-12 | 9.37 | 9.37 | 9.50 | 9.29 |
| Jun-13 | 9.24 | 9.13 | 9.33 | 9.08 |
| Jun-16 | 9.17 | 9.13 | 9.37 | 8.99 |
| Jun-17 | 9.03 | 8.81 | 9.21 | 8.81 |
| Jun-18 | 8.80 | 9.07 | 9.15 | 8.71 |
| Jun-20 | 9.17 | 9.04 | 9.18 | 8.96 |
Zevra Therapeutics Earnings
Zevra Therapeutics Earnings Report: Per Share Zevra Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Zevra Therapeutics Forecast Revenue Growth
Zevra Therapeutics Stock Analysis: Historical quarterly revenues per share for Zevra Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.37 per share, an increase next quarter of $0.20 per share, an increase this year of $3.02 per share, and a decrease next year of $0.45 per share.
* Zevra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.